|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0011860,
umls-concept:C0014257,
umls-concept:C0030705,
umls-concept:C0038250,
umls-concept:C0038435,
umls-concept:C0085403,
umls-concept:C0243192,
umls-concept:C0289313,
umls-concept:C0332307,
umls-concept:C1335238,
umls-concept:C1515655,
umls-concept:C1516240
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-7-10
|
|
pubmed:abstractText |
Endothelial progenitor cells (EPCs) are thought to contribute to endothelial recovery after arterial injury. We therefore compared in vivo reendothelialization capacity of EPCs derived from patients with diabetes mellitus and healthy subjects. Moreover, we examined the effect of treatment with the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone on oxidant stress, nitric oxide (NO) bioavailability, and the in vivo reendothelialization capacity of EPCs from diabetic individuals.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
pubmed-author:BahlmannFerdinand HFH,
pubmed-author:BeslerChristianC,
pubmed-author:DoerriesCarolaC,
pubmed-author:DrexlerHelmutH,
pubmed-author:FliserDaniloD,
pubmed-author:HallerHermannH,
pubmed-author:HorváthTiborT,
pubmed-author:KirchhoffNinaN,
pubmed-author:LandmesserUlfU,
pubmed-author:LimbourgAnneA,
pubmed-author:LimbourgFlorianF,
pubmed-author:MüllerMajaM,
pubmed-author:SchulzSvenjaS,
pubmed-author:SorrentinoSajoscha ASA
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
10
|
|
pubmed:volume |
116
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
163-73
|
|
pubmed:dateRevised |
2008-3-13
|
|
pubmed:meshHeading |
pubmed-meshheading:17592079-Aged,
pubmed-meshheading:17592079-Animals,
pubmed-meshheading:17592079-Blood Pressure,
pubmed-meshheading:17592079-Carotid Arteries,
pubmed-meshheading:17592079-Cholesterol,
pubmed-meshheading:17592079-Diabetes Mellitus, Type 2,
pubmed-meshheading:17592079-Diabetic Angiopathies,
pubmed-meshheading:17592079-Endothelial Cells,
pubmed-meshheading:17592079-Endothelium, Vascular,
pubmed-meshheading:17592079-Female,
pubmed-meshheading:17592079-Humans,
pubmed-meshheading:17592079-Male,
pubmed-meshheading:17592079-Mice,
pubmed-meshheading:17592079-Mice, Nude,
pubmed-meshheading:17592079-Middle Aged,
pubmed-meshheading:17592079-Models, Biological,
pubmed-meshheading:17592079-Nitric Oxide,
pubmed-meshheading:17592079-Oxidative Stress,
pubmed-meshheading:17592079-PPAR gamma,
pubmed-meshheading:17592079-Reference Values,
pubmed-meshheading:17592079-Stem Cells,
pubmed-meshheading:17592079-Superoxides,
pubmed-meshheading:17592079-Thiazolidinediones,
pubmed-meshheading:17592079-Vasodilator Agents
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
|
|
pubmed:affiliation |
Abteilung Kardiologie und Angiologie, Medizinische Hochschule Hannover, Hannover, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
